Table:
begin	end	state
1	11	non-cytoplasmic
12	31	transmembrane
32	59	cytoplasmic
60	83	transmembrane
84	88	non-cytoplasmic
89	109	transmembrane
110	137	cytoplasmic
138	157	transmembrane
158	174	non-cytoplasmic
175	194	transmembrane
195	202	cytoplasmic
203	224	transmembrane
225	230	non-cytoplasmic
231	255	transmembrane
256	293	cytoplasmic
294	315	transmembrane
316	338	non-cytoplasmic
339	360	transmembrane
361	377	cytoplasmic
378	393	transmembrane
394	398	non-cytoplasmic
399	422	transmembrane
423	483	cytoplasmic

Input:
>AO356_11095 FitnessBrowser__pseudo5_N2C3_1:AO356_11095
MLEVINDFLSGKVLIVLIVGLGGYFTIRSRFVQFRHFFHMFTVFRDSLKSSTDQLSSFQA
LMLSLAGRVGAGNIAGVGIAVTLGGPGAVFWMWVTALVGMSSSFFECSLGQLYKRCDSEG
QYRGGPSYYIQHGLQKRWLGMIMAFLLLVTFGFAFNGLQAHAVTHSLNNAFGFDTTYTGL
GLAVLLGLVFIGGIKRIAKVADLLVPVKTLAYIAVTLYVIVLQFEHVPGMLVTIVKSAFG
LDQAFGGLIGSAIVMGVKRGVFANEAGLGSAPNVAAVASVEHPVAQGVVQAFSVFLDTFV
ICTCTALLILLSGFYTPGFEGDGIALTQNSLAAVVGDWGRIFISVALSLFVFTSILYNYY
LGENNLRFMIGDNRKALMGYRALVLALIFWGAIENLGTVFAFADITMTLLAFVNLIALFL
LFKVGMRILRDYDDQRSAGIKVPVFDSSKFPDLDLDRKAWPANPSAPVAQPDAASAGVTA
AQR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server